In a retrospective study of individuals living with diabetes and obesity, conducted from 2008 through 2021, treatment with bariatric metabolic surgery was more effective than treatment with GLP-1 receptor agonists for prevention of incident congestive heart failure.
- Yael Wolff Sagy
- Gil Lavie
- Dror Dicker
